Novartis, Voyager sign gene therapy deal worth up to $1.3B

The companies have agreed to a collaboration and license agreement to develop gene therapies for Huntington ’s disease and spinal muscular atrophy.

Source: bizjournals.com Health Care:Biotechnology headlines - January 2, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news